Home>Topics>Stocks>Celgene Corporation

Celgene Corporation CELG

  1. All
  2. Commentary
  3. Headlines
    1. End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies

      Headlines

      Mon, 20 Oct 2014

      By BMD Asset Management and Research : October has historically been a weak month for biotech, with the Biotech Index underperforming the S&P 500 in 14 out the last 20 years. The current biotech sell-off was driven primarily by macro concerns and not sector fundamentals. This weakness is good for

    2. Cramer's Lightning Round - Ensco Is One Of The Worst Stocks I've Owned In My Life (10/17/14)

      Headlines

      Sun, 19 Oct 2014

      business. That stock has fallen way too hard compared to the good fundamentals." Gilead (NASDAQ: GILD ), Celgene (NASDAQ: CELG ), Regeneron (NASDAQ: REGN ): Cramer is bullish on these stocks. Molson Coors (NYSE: TAP ): "It is in the sweet spot

    3. Ad Comm meeting approaches for Novartis' psoriasis therapy candidate

      Headlines

      Thu, 16 Oct 2014

      systemic therapy or phototherapy. Briefing docs Psoriasis-related tickers: ( JNJ -1% )( DERM -5% )( MRK -2.2% )( CELG -0.9% )( IDRA +6.8% )( HSP +1.1% )( OTC:CANF )( AMGN -1.5% )( AZN -1.1% )( PFE -1.3% ) Post your

    4. Virobay on deck for IPO

      Headlines

      Tue, 7 Oct 2014

      MNOV +0.6% )( PFE -0.3% )( OTCPK:NGSX ) Psoriasis-related tickers: ( DERM -0.5% )( NVS -2.5% )( CELG -1.4% )( LLY -1.3% )( OTC:CANF -2.3% )( IDRA -1.4% )( JNJ -0.8% )( XNPT +0.5% )( HSP -0.2

    5. Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions

      Headlines

      Sat, 4 Oct 2014

      By James Sands : Individual Investor Portfolio - September 2014 Quarterly Update and Review At December 2013 year-end, the majority of the portfolio's holdings were liquidated in order to create a more diversified allocation of company holdings and to reduce risk. Each quarter the fund has improved

    6. Cramer's Lightning Round - Energy XXI Is The Worst Stock I've Ever Been Associated With (10/2/14)

      Headlines

      Fri, 3 Oct 2014

      LCI ): "I like that company. I like the generics. I like that situation." Gilead (NASDAQ: GILD ), Celgene (NASDAQ: CELG ): "Gilead is good. We have to see what they do with their cash. I do prefer Celgene." Bearish Calls: Energy XXI (NASDAQ

    7. Cramer's Mad Money - Are U.S. Oil Producers In Trouble? (10/2/14)

      Headlines

      Fri, 3 Oct 2014

      By SA Editor Miriam Metzinger : Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday October 2. Are American Oil Producers In Trouble? Stocks mentioned: Transocean (NYSE: RIG ), Ensco (NYSE: ESV ) Is the American renaissance in oil in trouble? The decline in the

    8. Celgene Is A Great Stock, But I Can't Manage To Hold Onto It

      Headlines

      Wed, 1 Oct 2014

      because I had a pretty good gain in the name and wanted to lock up some profits. I ended up buying shares of Celgene Corporation (NASDAQ: CELG ) because I wanted to buy into the biotech stock again. Celgene is a biopharmaceutical company. It is

    9. Celgene to report on October 23

      Headlines

      Wed, 1 Oct 2014

      Celgene (NASDAQ: CELG ) will report Q3 results on October 23 before the open. The conference call and webcast will begin at 9:00 am ET. Consensus view is EPS of $0.95 on revenues of $1.96B. Post your comment!

    10. Locking Up Profits In Visa Due To Global Turmoil

      Headlines

      Wed, 1 Oct 2014

      because I had a pretty good gain in name and wanted to lock up some profits. I ended up buying shares of Celgene Corporation (NASDAQ: CELG ) because I wanted to buy into the biotech stock again. Visa is a global payments and technology company

    « Prev12345Next »
    Content Partners